Octavius Pharma

Ahmedabad, India Founded: 2004 • Age: 22 yrs
Produces pharmaceutical formulations, supplements, and granules for global export markets.

About Octavius Pharma

Octavius Pharma is a Healthcare company based in Ahmedabad (India) founded in 2004. It produces pharmaceutical formulations, supplements, and granules for global export markets. It operates on a B2B and Export model. Its Indian entity Octavius Pharma Private Limited reported revenue of β‚Ή30.43 Cr. Octavius Pharma offers products and services including DC Granules, Finished Formulations, Herbal Supplements, Pellets, and Herbal Extracts. Its focus areas include Food and Agriculture Tech, Nutraceuticals, Supplements and Herbal Extracts. Similar companies include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed similar companies has raised funding.

Company details

Octavius Pharma is a pharmaceutical manufacturer and exporter based in India, specializing in producing high-quality DC Granules, finished formulations, herbal supplements, pellets, and herbal extracts. They offer services like contract manufacturing, formulation development, and technology transfer to support healthcare needs. Operating from Ahmedabad, they comply with global standards and serve international clients through B2B partnerships.

Key Metrics
  • Annual Revenue
    ₹30.43 Cr

    FY 2025 · +169% YoY

  • Net Profit
    ₹5.41 Cr

    FY 2025 · 18% margin

  • EBITDA
    ₹7.88 Cr

    FY 2025 · 26% margin

Products & Services of Octavius Pharma

Octavius Pharma offers a comprehensive portfolio of products and services, including DC Granules, Finished Formulations, Herbal Supplements, Pellets, and Herbal Extracts.

DC Granules
Raw Materials

High-quality granules for pharmaceutical use in drug production.

Finished Formulations
Drug Products

Formulations that enhance health and quality of life.

Herbal Supplements
Nutraceuticals

Supplements addressing nutritional needs with safe ingredients.

Pellets
Pharmaceutical Components

Precisely engineered pellets for medical applications.

Herbal Extracts
Natural Products

Extracts meeting diverse consumer health requirements.

Board of directors of Octavius Pharma Private Limited (Octavius Pharma)

Octavius Pharma Private Limited is the primary company behind Octavius Pharma. The board of Octavius Pharma Private Limited currently have 4 directors; the longest-serving is Deepakkumar Jayantilal Padia, appointed in 2004. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Deepakkumar Jayantilal Padia
DIN 00388709
Director23 Apr 200422 yrs 6 moOctavius Pharma Private Limited
Jyotiben Dipakkumar Padia
DIN 02862906
Director23 Apr 200422 yrs 6 moOctavius Pharma Private Limited
Kirtan Padia Deepakkumar
DIN 01610722
Director23 Apr 200422 yrs 6 moOctavius Pharma Private Limited
Nirali Kirtan Padia
DIN 08203754
Director21 Aug 20188 yrs 2 moOctavius Pharma Private Limited

Financials of Octavius Pharma

Figures of Octavius Pharma Private Limited, the primary company behind Octavius Pharma, for FY 2025. Revenue was ₹30.43 Cr (+169% year on year). Net profit was ₹5.41 Cr (18% margin). EBITDA was ₹7.88 Cr (26% margin). Revenue has grown at a compounded annual rate of +60% over three years and +40% over five years.

  • ₹30.43 CrRevenue · FY 2025 · +169% YoY
  • ₹5.41 CrNet profit · 18% margin
  • ₹7.88 CrEBITDA · 26% margin
  • ₹1 LakhPaid-up capital
  • +60%Revenue CAGR, 3 years
  • +40%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Octavius Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Octavius Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Octavius Pharma

Octavius Pharma has 3 listed similar companies in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
Premium access

Detailed similar companies of Octavius Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Octavius Pharma

The website of Octavius Pharma (octaviuspharma.com) receives about 1.7K visits a month.

  • Monthly visits
    1.7K

    ▲ 7.4% vs previous month

Similar websites

Websites whose visitors overlap most with Octavius Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
phytoextractskp.com
90%
1.5KView details

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Octavius Pharma (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M5,180
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.21 B25,870
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Octavius Pharma

Octavius Pharma was founded in 2004.

Octavius Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind Octavius Pharma, Octavius Pharma Private Limited, reported revenue of β‚Ή30.43 Cr for FY 2025, up 169% year on year.

Octavius Pharma is a pharmaceutical manufacturer and exporter based in India, specializing in producing high-quality DC Granules, finished formulations, herbal supplements, pellets, and herbal extracts. They offer services like contract manufacturing, formulation development, and technology transfer to support healthcare needs. Operating from Ahmedabad, they comply with global standards and serve international clients through B2B partnerships.

Octavius Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.

Octavius Pharma offers DC Granules, Finished Formulations, Herbal Supplements, Pellets, and Herbal Extracts.

Octavius Pharma operates through Octavius Pharma Private Limited.

The legal entities of Octavius Pharma currently have 4 directors, including Deepakkumar Jayantilal Padia, Jyotiben Dipakkumar Padia, Kirtan Padia Deepakkumar and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available